Evaxion Biotech A/S ADR (NASDAQ: EVAX) is 42.65% higher on its value in year-to-date trading and has touched a low of $2.38 and a high of $68.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EVAX stock was last observed hovering at around $3.64 in the last trading session, with the day’s gains setting it 2.39%.
Currently trading at $6.03, the stock is 45.31% and 2.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 55.64 million and changing 65.66% at the moment leaves the stock -55.23% off its SMA200. EVAX registered -75.83% loss for a year compared to 6-month loss of -59.29%. The firm has a 50-day simple moving average (SMA 50) of $5.90628 and a 200-day simple moving average (SMA200) of $13.46907.
The stock witnessed a 31.09% gain in the last 1 month and extending the period to 3 months gives it a -52.89%, and is 79.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 50.40% over the week and 22.16% over the month.
Evaxion Biotech A/S ADR (EVAX) has around 49 employees, a market worth around $7.06M and $3.30M in sales. Profit margin for the company is -348.07%. Distance from 52-week low is 153.36% and -91.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-102.11%).
with sales reaching $1.66M over the same period.The EPS is expected to grow by 89.88% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Evaxion Biotech A/S ADR (EVAX) Top Institutional Holders
Evaxion Biotech A/S ADR (EVAX) Insider Activity
#####
